Bone Resorption, Osteoclastogenesis and Adalimumab
Clinical trial NCT02035800 · UNKNOWN
Trial details
- NCT number
- NCT02035800
- Sponsor
- Université de Sherbrooke
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2018-12-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.